Chronic inflammation and the evasion of apoptosis are hallmarks of cancer [25], hence it is no surprise that there is an abundance of emerging evidence supporting a role for p50 homodimers as tumour-suppressors. The gene discussed is NFKB1; the disease is neoplasm.